Christian Kappeler

Author PubWeight™ 6.38^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial.	Lancet	2012	5.62
2	Rationale and design of decision: a double-blind, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of sorafenib in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory, differentiated thyroid cancer.	BMC Cancer	2011	1.24